Matthew Scott Harris - Mar 7, 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Medical Officer
Signature
/s/ Greg Weaver, as Attorney-in Fact
Stock symbol
ALT
Transactions as of
Mar 7, 2025
Transactions value $
$0
Form type
4
Date filed
3/11/2025, 04:05 PM
Previous filing
Feb 3, 2025
Next filing
Aug 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Gift $0 -67.8K -82.81% $0.00 14.1K Mar 7, 2025 Direct F1
holding ALT Common Stock, par value $0.0001 67.8K Mar 7, 2025 By Matthew Scott Harris Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 7, 2025, the reporting person transferred 67,787 shares of common stock to the Matthew Scott Harris Trust for no consideration. The reporting person is trustee of the trust, and the reporting person and members of his immediate family are the sole beneficiaries of the trust. The reporting person remains the beneficial owner of the securities held by the trust.